Lv11
60 积分 2022-02-25 加入
10 pack-years of smoking: not the magic number for COPD risk and prognosis
4小时前
待确认
An open-label phase 2a study investigating the efficacy and safety of a cathepsin S inhibitor in patients with moderate-to-severe psoriasis
3个月前
已关闭
Roflumilast—an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial
5个月前
已关闭
[Research progress in potential drugs for chronic obstructive pulmonary disease therapy]
5个月前
已完结
Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trial
6个月前
已完结
The FLT3-like Gene Expression Signature Predicts Response to Quizartinib in Wild-Type FLT3 Acute Myeloid Leukemia: An Analysis of the Pethema Quiwi Trial
6个月前
已关闭
Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trial
6个月前
已完结
Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trial
6个月前
已完结
Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial
6个月前
已完结
CD8 cis-targeted IL-2 drives potent antiviral activity against hepatitis B virus
6个月前
已完结
皖公网安备34019202002308
